Affordable Access

Publisher Website

Outcome of multimodal treatment for oropharyngeal carcinoma: A single institution experience

Oral Oncology
Publication Date
DOI: 10.1016/j.oraloncology.2006.04.015
  • Oropharyngeal Carcinoma
  • Radiotherapy
  • Surgery
  • Survival
  • Multimodal Therapy
  • Economics
  • Medicine


Summary The clinical management of patients with primary oropharyngeal squamous cell carcinoma remains controversial. The results of a combined approach involving surgery for the primary tumor, neck dissection, and postoperative radiotherapy were reviewed. A retrospective review was carried out for 211 patients meeting the inclusion criteria of resectable squamous cell carcinoma of the oropharynx. Overall survival and disease-free survival rates were calculated using the Kaplan–Meier method. Univariate (Log-rank test) and multivariate (Cox proportional hazards models) statistical analyses were carried out to investigate the role of clinical factors as significant prognostic markers. The 2- and 5-year disease-free survival rates were 79.8% and 68.8%, respectively. In univariate and multivariate analyses, positive resection margins were the only and independent significant prognostic markers for impaired disease-free survival (Log-rank: p = 0.0238; Cox model: p = 0.045; hazard ratio 2.48 [95% confidence interval 1.02–6.05]). In univariate analysis, male sex was the only significant negative prognostic factor for overall survival (Log-rank: p = 0.0453), whereas Cox multivariate analysis identified extracapsular spread as an independent prognostics marker ( p = 0.049; hazard ratio 1.86 [95% confidence interval 1.00–3.43]). We conclude that the presented multimodal approach of surgery for the primary tumor and the neck followed by postoperative radio(chemo)therapy seems to be superior to non-surgical treatment protocols, as it results in better disease-free and overall survival. To assess this multimodal treatment approach, morbidity and economic considerations need to be further analyzed.

There are no comments yet on this publication. Be the first to share your thoughts.